Device / Technology News

RSS

Apnex HGNS System shows promising results in people suffering from OSA

Apnex Medical announced today that preliminary data from a first-in-man clinical study showed significant improvements in sleep for people suffering from obstructive sleep apnea. The Apnex HGNS™ System, developed by the St. Paul-based company, is a device designed to treat OSA, which is a serious life-threatening illness characterized by fragmented sleep and excessive day-time sleepiness.

18 May 2010

Sonablate HIFU treatment now available in Bermuda for patients with prostate cancer

US HIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound technologies, is pleased to announce that its HIFU treatment for prostate cancer is now available in Bermuda. King Edward VII Memorial Hospital in Bermuda joins more than 100 centers in 30-plus countries to offer the innovative treatment with the Sonablate 500 medical device.

18 May 2010

Cynosure's proprietary aesthetic laser systems receive regulatory approvals in Asia and South America

Cynosure, Inc., today announced four international regulatory approvals that extend the reach of the company's proprietary aesthetic laser systems in Asia and South America.

18 May 2010

Ambry Genetics launches AmbryScreen test for genetic screening of severe, common childhood diseases

Ambry Genetics announced today at the American College of Obstetricians and Gynecologists annual clinical meeting the launch of AmbryScreen™, a genetic screening test used to identify carriers of some of the most severe and common childhood diseases affecting pan-ethnic populations.

18 May 2010

Cardiocom releases new pulse oximeter

Cardiocom today announced the release of its new pulse oximeter. Cardiocom's internally developed pulse oximeter offers better integration with its telehealth platform. Cardiocom designs and manufactures telehealth communication devices and vital sign peripherals including: blood pressure system, weight scale, and now offers its new pulse oximeter.

17 May 2010

BaroFold licenses PreEMT Technology to Nuron Biotech for development of BaroFeron

BaroFold, Inc. today announced that it has entered into an agreement to exclusively license its PreEMT™ Technology to Nuron Biotech for the development of BaroFeron™ and follow-on interferon beta products. BaroFeron is a proprietary recombinant human interferon beta being developed for the treatment of multiple sclerosis. Specific terms of the agreement are not disclosed.

17 May 2010

Health Robotics re-acquires European rights for CytoCare from B. Braun

Health Robotics and B. Braun Melsungen AG today announced that in exchange for undisclosed consideration, Health Robotics has re-acquired from B. Braun the exclusive marketing, sales, installation, implementation, interface, manufacturing, and technical support European rights for CytoCare, a robot designed to manufacture chemotherapy and hazardous IV Admixtures, and which rights B. Braun had previously acquired from Health Robotics in 2007 and 2008.

From B. Braun Melsungen AG 17 May 2010

Hospitals to get more bargaining clout for medical devices

The Wall Street Journal: "Hospitals lack leverage when negotiating prices for high-cost implants like defibrillators and replacement hips because individual doctors, rather than hospitals, typically select the products they use in their patients. Since these doctors often aren't hospital employees, they have little incentive to bargain-hunt.

17 May 2010

Dehaier Medical Systems becomes exclusive China distributor of Welch Allyn's patient monitors

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical products in China, said today that it has become the exclusive China distributor of Welch Allyn's patient monitors.

17 May 2010

Aastrom Biosciences initiates treatment in Phase 2 catheter-based clinical trial for dilated cardiomyopathy

Aastrom Biosciences, Inc., the leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the first patient has been treated in the company's U.S. Phase 2 catheter-based clinical trial to treat dilated cardiomyopathy (DCM). Treatment was performed by interventional cardiologist Timothy D. Henry, M.D., FACC, at the Minneapolis Heart Institute® at Abbott Northwestern Hospital in Minneapolis, MN.

17 May 2010

TriReme Medical receives FDA expanded clearance for GliderXtreme PTA balloon catheter

TriReme Medical, Inc. (TMI) announced today that it has received FDA clearance for an expanded matrix of sizes for its GliderXtreme™ PTA balloon catheter. GliderXtreme™ is now approved for the percutaneous transluminal treatment of lesions in the peripheral vasculature in balloon diameters from 2.0 – 5.0mm and in balloon lengths up to 200mm.

17 May 2010

Freescale Semiconductor receives ZigBee Certification for wireless health and wellness solutions

Freescale Semiconductor today announced it has received ZigBee Certified product status for its ZigBee Health Care wireless health and wellness processing platforms. The ZigBee Certified products status is awarded to products that have been tested and met criteria for interoperability that enable wireless devices to securely and reliably monitor and manage noncritical, low-acuity health care services.

17 May 2010

AngioDynamics launches Morpheus Smart PICC Triple Lumen CT PICC

AngioDynamics announced today the launch of the first member of its new generation of peripherally inserted central catheters (PICCs) for procedures involving the use of contrast media in computed tomography (CT) - the Morpheus Smart PICC Triple Lumen CT PICC.

17 May 2010

MicroStockProfit.com: BSMD's total worldwide revenues for first-quarter 2010 decline 2%

MicroStockProfit.com announces an investment report featuring BioSphere Medical Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

17 May 2010

Berman Institute experts available for comment on direct-to-consumer marketing of genetic test kits

Journalists covering the recent announcement by Pathway Genomics that it will sell health-related genetic marker tests to consumers—and the subsequent decision by Walgreens to postpone sales of the kits pending clarification of their legal status—are invited to interview Berman Institute experts Joan Scott or Gail Javitt.

17 May 2010

NPL launches new Measurement Network

The National Physical Laboratory is launching a new Measurement Network to provide comprehensive access to the latest measurement science. It will bring together nineteen existing NPL knowledge transfer clubs and networks into a central hub - making it easier for a wide range of stakeholders to engage with NPL and for new groups to develop as technologies change.

17 May 2010

FDA has right to request more information from genetic testing kit manufacturers: Law Professor

"The FDA was right to request more information from the manufacturer of the genetic testing kit before its sale to consumers," says IU School of Law-Indianapolis Professor David Orentlicher.

17 May 2010

Blood-flow fMRI to be used to study brain-wide impact of neural circuitry changes

Like a motorist who knows that the "check engine" light indicates something important but ill-defined is happening, neuroscientists have relied heavily on an incompletely understood technology called functional magnetic resonance imaging to show them what the brain is doing when people respond to different stimuli.

17 May 2010

New data from MVP trial on ICDs shows health care use burden

Medtronic, Inc. today released new data from the MVP trial that implantable defibrillator patients receiving anti-tachycardia pacing were less likely to have health care utilization after treatment as compared to those receiving shock therapy.

17 May 2010

UNC-developed technique has broad applications in cancer, biomedical research

A precise understanding of cellular growth and movement is the key to developing new treatments for cancer and other disorders caused by dysfunctional cell behavior. Recent breakthroughs in genetic medicine have uncovered how genes control whether cellular proteins are turned 'on' or 'off' at the molecular level, but much remains to be understood about how protein signaling influences cell behavior.

17 May 2010

Device / Technology News

Apnex HGNS System shows promising results in people suffering from OSA

Sonablate HIFU treatment now available in Bermuda for patients with prostate cancer

Cynosure's proprietary aesthetic laser systems receive regulatory approvals in Asia and South America

Ambry Genetics launches AmbryScreen test for genetic screening of severe, common childhood diseases

Cardiocom releases new pulse oximeter

BaroFold licenses PreEMT Technology to Nuron Biotech for development of BaroFeron

Health Robotics re-acquires European rights for CytoCare from B. Braun

Hospitals to get more bargaining clout for medical devices

Dehaier Medical Systems becomes exclusive China distributor of Welch Allyn's patient monitors

Aastrom Biosciences initiates treatment in Phase 2 catheter-based clinical trial for dilated cardiomyopathy

TriReme Medical receives FDA expanded clearance for GliderXtreme PTA balloon catheter

Freescale Semiconductor receives ZigBee Certification for wireless health and wellness solutions

AngioDynamics launches Morpheus Smart PICC Triple Lumen CT PICC

MicroStockProfit.com: BSMD's total worldwide revenues for first-quarter 2010 decline 2%

Berman Institute experts available for comment on direct-to-consumer marketing of genetic test kits

NPL launches new Measurement Network

FDA has right to request more information from genetic testing kit manufacturers: Law Professor

Blood-flow fMRI to be used to study brain-wide impact of neural circuitry changes

New data from MVP trial on ICDs shows health care use burden

UNC-developed technique has broad applications in cancer, biomedical research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News